AeroLeads people directory · profile

Hans Brightbill Email & Phone Number

Scientific Director, In Vivo Pharmacology - Inflammation Research, Amgen at Amgen
Location: San Francisco, California, United States 13 work roles 3 schools
3 work emails found @gene.com 1 phone found area 510 LinkedIn matched
✓ Verified May 2026 4 data sources Profile completeness 100%

Contact Signals · 3 work emails · 1 phone

Work email b****@gene.com
Direct phone (510) ***-****
LinkedIn Profile matched
3 free lookups remaining · No credit card
Current company
Role
Scientific Director, In Vivo Pharmacology - Inflammation Research, Amgen
Location
San Francisco, California, United States

Who is Hans Brightbill? Overview

A concise factual answer block for searchers comparing this professional profile.

Quick answer

Hans Brightbill is listed as Scientific Director, In Vivo Pharmacology - Inflammation Research, Amgen at Amgen, based in San Francisco, California, United States. AeroLeads shows a work email signal at gene.com, phone signal with area code 510, and a matched LinkedIn profile for Hans Brightbill.

Hans Brightbill previously worked as Scientific Director, In Vivo Pharmacology - Inflammation at Amgen and Review Editor at Frontiers In Immunology. Hans Brightbill holds Ph.D., Microbiology And Immunology from Ucla.

Company email context

Email format at Amgen

This section adds company-level context without repeating Hans Brightbill's masked contact details.

{last}.{first}@gene.com
92% confidence

AeroLeads found 3 current-domain work email signals for Hans Brightbill. Compare company email patterns before reaching out.

Profile bio

About Hans Brightbill

Hans Brightbill is a Scientific Director, In Vivo Pharmacology - Inflammation Research, Amgen at Amgen. He possess expertise in immunology, cell, molecular biology, cell biology, cell culture and 14 more skills.

Listed skills include Immunology, Cell, Molecular Biology, Cell Biology, and 15 others.

Current workplace

Hans Brightbill's current company

Company context helps verify the profile and gives searchers a useful next step.

Amgen
Amgen
Scientific Director, In Vivo Pharmacology - Inflammation Research, Amgen
Website
AeroLeads page
13 roles · 34 years

Hans Brightbill work experience

A career timeline built from the work history available for this profile.

Scientific Director, In Vivo Pharmacology - Inflammation

Current

Thousand Oaks, CA, US

Jun 2024 - Present

Review Editor

Current
Frontiers In Immunology
Nov 2022 - Present

Voting Member, Institutional Animal Care And Use Committee (Iacuc)

South San Francisco, California, US

Jan 2023 - Jun 2024

Principal Scientific Manager (Group Leader), Translational Immunology

South San Francisco, California, US

Publications:Sun. T., Huang, Z., Liang, W.C., Yin, J., Lin, W.Y., Wu, J., Vernes, J.M., Lutman, J., Caplazi, P., Jeet, S., Wong, T., Wong, M., DePianto, D.J., Morshead, K.B., Sun, K.H., Modrusan, Z., Vander Heiden, J.A., Abbas, A.R., Zhang, H., Xu, M., N'Diaye, E.N., Roose-Girma, M., Wolters, P.J., Yadav, R., Sukumaran, S., Ghilardi, N., Corpuz, R., Emson.

Jul 2020 - Jun 2024

Interim Fibrosis Disease Area Strategy Lead

South San Francisco, California, US

Jul 2021 - Jan 2023

Senior Scientific Manager (Lab Head), Translational Immunology

South San Francisco, California, US

Awards:2019 Research Biology Recognition AwardPublications:Corzo C., U., et al. The kinase IRAK4 promotes endosomal TLR and immune complex signaling in B cells and plasmacytoid dendritic cells. Science Signaling 13:eaaz1053. Doi:10.1126/scisignal.aaz1053 (2020).Rajapaksa, N.S., et al. Discovery of Potent Benzolactam IRAK4 Inhibitors with Robust in Vivo.

Jan 2018 - Jul 2020

Senior Principal Scientific Researcher(Scientist 4)-Manager, Immunology Discovery Smi Assay Core Lab

South San Francisco, California, US

Biology Lead for NIK small molecule program.Publications:Brightbill HD, et al. (2017) NF-kB inducing kinase is a therapeutic target for systemic lupus erythematosus. Nature Communications 9:179.Castanedo GM, et al. (2017) Structure-Based Design of Tricyclic NF-κB Inducing Kinase (NIK) Inhibitors That Have High Selectivity over Phosphoinositide-3-kinase.

Sep 2015 - Jan 2018

Principal Scientific Researcher (Scientist 3), Immunology

South San Francisco, California, US

R&D. Basic research and therapeutics for the treatment of allergy, asthma, and autoimmune disease.THERAPEUTIC PROJECTS:Quilizumab, anti-M1'​-IgE. Late stage, Early Development, IND Filing. 2007, 2009.Small Molecule therapeutic. Late stage transition, 2014.PRESENTATIONS:Keystone Symposium: The NF-κB System in Health and Disease, Keystone, CO, 2014. Poster.

Jan 2006 - Aug 2015

Associate Specialist

Berkeley, CA, US

Research on the role of c-Abl in early B cell development and survival. 2004-2005: National Institutes of Health Fellowship, #CA09179-29.

Jul 2005 - Jan 2006

Post-Doctoral Fellow

Berkeley, CA, US

AWARDS:2001-2004. Leukemia and Lymphoma Society Fellowship #5325-02.

May 2000 - Jun 2005

Undergraduate Researcher

Irvine, CA, US

PUBLICATIONS:Burger, R.A., et al. (1994) Host-tumor interaction in ovarian cancer. Spontaneous release of Tumor Necrosis Factor and Interluekin-1 inhibitors by purified cell populations form human ovarian carcinoma in vitro. Gynecol. Oncol. 55:294 – 303.Abe, Y., M. et al. (1993) The role of lymphotoxin in the IL-2-driven differentiation of human.

1992 - 1994 ~2 yrs
Team & coworkers

Colleagues at Amgen

Other employees you can reach at amgen.com. View company contacts →

3 education records

Hans Brightbill education

Ph.D., Microbiology And Immunology

Ucla

B.S. Biological Sciences, B.M. Cello Performance, Biological Sciences, Music

Uc Irvine

Education record

Dana Hills High School
FAQ

Frequently asked questions about Hans Brightbill

Quick answers generated from the profile data available on this page.

What company does Hans Brightbill work for?

Hans Brightbill works for Amgen.

What is Hans Brightbill's role at Amgen?

Hans Brightbill is listed as Scientific Director, In Vivo Pharmacology - Inflammation Research, Amgen at Amgen.

What is Hans Brightbill's email address?

AeroLeads has found 3 work email signals at @gene.com for Hans Brightbill at Amgen.

What is Hans Brightbill's phone number?

AeroLeads has found 1 phone signal(s) with area code 510 for Hans Brightbill at Amgen.

Where is Hans Brightbill based?

Hans Brightbill is based in San Francisco, California, United States while working with Amgen.

What companies has Hans Brightbill worked for?

Hans Brightbill has worked for Amgen, Frontiers In Immunology, Genentech, Uc Berkeley, and Ucla, Department Of Microbiology And Immunology, School Of Medicine.

Who are Hans Brightbill's colleagues at Amgen?

Hans Brightbill's colleagues at Amgen include Alli Moeller, Omid Zadakbar, Phd, Ccpsc®, Cbcp, David Perkins, Adam Biddlecome, and Carissa Childs.

How can I contact Hans Brightbill?

You can use AeroLeads to view verified contact signals for Hans Brightbill at Amgen, including work email, phone, and LinkedIn data when available.

What schools did Hans Brightbill attend?

Hans Brightbill holds Ph.D., Microbiology And Immunology from Ucla.

What skills is Hans Brightbill known for?

Hans Brightbill is listed with skills including Immunology, Cell, Molecular Biology, Cell Biology, Cell Culture, Elisa, Science, and Tissue Culture.

Find 750M verified contacts

Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.